This article is a commentary on:
Mutual Interaction of Basophils and T Cells in Chronic Inflammatory Diseases
Salvatore Chirumbolo- Unit of Geriatry, Department of Medicine, University Laboratory of Medical Research-LURM est, Policlinico GB Rossi, Verona, Italy
A commentary on
Sarfati et al. recently published a thorough overview on the role exerted by basophils in the immune system and their relationship with T cells in chronic inflammation (1). In their paper, the authors fundamentally referred to the relationship with T cells, and basophil participation in innate and acquired immunity, through the complex network of immune cells and cytokines. Many further, though less appealing, mediators should be introduced, yet.
The paper by Sarfati et al. contains interesting bullet points on the biology of basophils, which deserve further insights and raise also some concern about the use and meaning of these cells in immunology laboratory (2). Allergy tests usually consider basophils as independent leukocytes able to elicit or regulate a typical type I hypersensitivity reaction, most commonly reported as an allergic response. Therefore, in this perspective, basophils are investigated fundamentally by the membrane recycling and up- or downregulation of IgE-induced surface displaced molecules, which undergo a turn over mechanism due to the basophil-mediated immune response. Actually, these cells play a pivotal role in the immune system and even their use in allergy diagnosis should be reappraised (3, 4). This would mean that basophils need to be treated not only as isolated cells responding to allergens but also as innate T-cells, quite neglecting their close interaction with other immune cells such as T-cells, platelets or other leukocytes. Yet, basophils appear to interact with a wide group of immune cells, either from innate or acquired immunity, particularly in chronic inflammation. In this scenario, lipid-derived molecules might play a major role also for basophils.
During allergy, leukocytes produce many mediators, some of which of recent interest, such as 15-hydroxyeicosatetraenoic acid (15-HETE) (5). This endogenous eicosanoid can interact with basophils, which possess receptors for 15-HETE (6) or bind to intracellular non G-coupled receptors such as PPAR-γ, which is expressed also in basophils (7). Aside from the overview described by the authors, this issue may be important during chronic allergic inflammation. Recent reports have shown that the activity of 15-lipooxygenase type 1 (15-LO-1) is fundamental in causing pathophysiology of asthma. During an inflammatory or physical injury, human airway epithelial cells increase their 15-LO-1 activity and the production of 15-HETE, besides the production of eoxin C4 (EXC4) or 14,15-leukotriene C4, from arachidonic acid (8). Basophils express cysteinyl leukotriene receptors (CysLTR) (9), CysLTR1 and 2 are upregulated in macrophages by IL-4 and IL-13 (10) and interact each other to regulate mitogenic signaling responses in mast cells (11). Cysteinyl leukotrienes (CysLTs) are important molecules produced by basophils, eosinophils, mast cells, and macrophages during innate immunity and in this sense represent important molecules to be focused when talking about basophils involvement in chronic inflammation (12). The authors questioned of how basophils are recruited to the site of inflammation and referred to CRTH2 (PGD2 receptor) and IL-3 receptor as possible target molecules for recruitment (1). At least for eosinophils, evidence suggested that CysLRRs are associated with the recruitment of these leukocytes in the site of allergic inflammation (13). To date, no information was reported about the possible involvement of these receptors in basophil diapedesis but this issue deserves major interest, due the role exerted in eosinophils. Basophils express LTC4, which is consequently transformed into LTD4 and the more stable LTE4 and in this sense they actively participate in asthma and control, through CysLTRs the induction of a Th2-mediated response to allergens (14). Actually, past data from cysteinyl leucotriene receptors antagonists confirm the role of these mediators in allergic asthma (15). This perspective may encourage researchers in evaluating CysLTRs markers on basophil membrane to improve cellular tests used for allergy diagnosis. During activation, basophils express a group of membrane molecules, which should provide clues about the role of these cells in the allergic inflammation, if selected as primary markers in a flow cytometry assay, such as the basophil activation test (BAT). While most common markers probing activated basophils are CD63 and CD203c, these molecules change their membrane expression directly linked to cell activation and independently from an IgE- or a non-IgE-mediated stimulus. Newly incoming markers might help researchers in differentiating the role of basophils in innate or acquired immunity. For example, the BM16 monoclonal antibody, which reacts with CD294, the prostaglandin D2 receptor, may give insights on the role of PGD2 in allergic inflammation, as PGD2 metabolites are well recognized markers of allergy, particularly for mast cells (16, 17). The search for new target molecules, either for allergy treatment or lab investigation, is a major goal for the development of novel approaches in diagnosis and therapy (18). In addition, the 2-oxoglutarate receptor 1 (OXGR1), a new cysteinyl receptor called receptor of the CysLTE or GPR99, is expressed in mast cells and its ligand LTE4 is able to recruit both eosinophils and basophils to the inflammatory site in asthma (19). Products from 5-lipooxygenase regulate basophil migration (5-oxo-ETE) and degranulation (LTB4) (20), then the role of these mediators in chronic inflammation involving basophils should be reappraised. CysLTs, particularly CysLT1, activate the recruitment of both alpha–beta and gamma–delta effector T cells to the inflamed tissue (21). During allergy, T cells increase their expression of CyLTRs (22), an evidence that would suggest the fundamental role exerted by Cys-leukotrienes in the relationship basophils/T cells, during inflammation.
The conclusion, which the authors reached, describes a landscape where basophils play a strategic role at the cross-road of innate and acquired immunity, and in this sense, they reported a commonly accepted overview of the problem (23). Further insights about the function of lipid mediators in this complex basophil/T cell interplay might improve our knowledge and comprehension about the role of basophils in chronic inflammation.
Author Contributions
The author confirms being the sole contributor of this work and approved it for publication.
Conflict of Interest Statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Sarfati M, Wakahara K, Chapuy L, Delespesse G. Mutual interaction of basophils and T cells in chronic inflammatory diseases. Front Immunol (2015) 6:399. doi:10.3389/fimmu.2015.00399
2. Siracusa MC, Kim BS, Spergel JM, Artis D. Basophils and allergic inflammation. J Allergy Clin Immunol (2013) 132(4):789–801. doi:10.1016/j.jaci.2013.07.046
3. Uyttebroek AP, Sabato V, Faber MA, Cop N, Bridts CH, Lapeere H, et al. Basophil activation tests: time for a reconsideration. Expert Rev Clin Immunol (2014) 10(10):1325–35. doi:10.1586/1744666X.2014.959498
4. Chirumbolo S. Basophil activation test in allergy: time for an update? Int Arch Allergy Immunol (2012) 158(2):99–114. doi:10.1159/000331312
5. Michalak A, Lewandowska-Polak A, Moskwa S, Kowalski ML, Grzegorczyk JŁ. IgE-mediated 15-hydroxyeicosatetraenoic acid (15-HETE) generation by peripheral blood leukocytes: its association with basophil activation. Postepy Dermatol Alergol (2015) 32(4):262–7.
6. Vonakis BM, Vanderhoek JY. 15-Hydroxyeicosatetraenoic acid (15-HETE) receptors. Involvement in the 15-HETE-induced stimulation of the cryptic 5-lipoxygenase in PT-18 mast/basophil cells. J Biol Chem (1992) 267(33):23625–31.
7. Fujimura Y, Tachibana H, Yamada K. Peroxisome proliferator-activated receptor ligands negatively regulate the expression of the high-affinity IgE receptor Fc epsilon RI in human basophilic KU812 cells. Biochem Biophys Res Commun (2002) 297(2):193–201. doi:10.1016/S0006-291X(02)02139-3
8. Brunnström Å, Tryselius Y, Feltenmark S, Andersson E, Leksell H, James A, et al. On the biosynthesis of 15-HETE and eoxin C4 by human airway epithelial cells. Prostaglandins Other Lipid Mediat (2015) 121(Pt A):83–90. doi:10.1016/j.prostaglandins.2015.04.010
9. Gauvreau GM, Plitt JR, Baatjes A, MacGlashan DW. Expression of functional cysteinyl leukotriene receptors by human basophils. J Allergy Clin Immunol (2005) 116(1):80–7. doi:10.1016/j.jaci.2005.03.014
10. Thivierge M, Stanková J, Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol (2001) 167(5):2855–60. doi:10.4049/jimmunol.167.5.2855
11. Jiang Y, Borrelli LA, Kanaoka Y, Bacskai BJ, Boyce JA. CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood (2007) 110(9):3263–70. doi:10.1182/blood-2007-07-100453
12. Theron AJ, Steel HC, Tintinger GR, Gravett CM, Anderson R, Feldman C. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function. J Immunol Res (2014) 2014:608930. doi:10.1155/2014/608930
13. Saito H, Morikawa H, Howie K, Crawford L, Baatjes AJ, Denburg E, et al. Effects of a cysteinyl leukotriene receptor antagonist on eosinophil recruitment in experimental allergic rhinitis. Immunology (2004) 113(2):246–52. doi:10.1111/j.1365-2567.2004.01944.x
14. Laidlaw TM, Boyce JA. Cysteinyl leukotriene receptors, old and new; implications for asthma. Clin Exp Allergy (2012) 42(9):1313–20. doi:10.1111/j.1365-2222.2012.03982.x
15. Jarvis B, Markham A. Montelukast: a review of its therapeutic potential in persistent asthma. Drugs (2000) 59(4):891–928. doi:10.2165/00003495-200059040-00015
16. O’Sullivan S. On the role of PGD2 metabolites as markers of mast cell activation in asthma. Acta Physiol Scand Suppl (1999) 644:1–74.
17. Moon TC, Campos-Alberto E, Yoshimura T, Bredo G, Rieger AM, Puttagunta L, et al. Expression of DP2 (CRTh2), a prostaglandin D2 receptor, in human mast cells. PLoS One (2014) 9(9):e108595. doi:10.1371/journal.pone.0108595
18. Harvima IT, Levi-Schaffer F, Draber P, Friedman S, Polakovicova I, Gibbs BF, et al. Molecular targets on mast cells and basophils for novel therapies. J Allergy Clin Immunol (2014) 134(3):530–44. doi:10.1016/j.jaci.2014.03.007
19. Kanaoka Y, Maekawa A, Austen KF. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand. J Biol Chem (2013) 288(16):10967–72. doi:10.1074/jbc.C113.453704
20. Iikura M, Suzukawa M, Yamaguchi M, Sekiya T, Komiya A, Yoshimura-Uchiyama C, et al. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation. J Allergy Clin Immunol (2005) 116(3):578–85. doi:10.1016/j.jaci.2005.04.029
21. Prinz I, Gregoire C, Mollenkopf H, Aguado E, Wang Y, Malissen M, et al. The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse alpha beta- and gamma delta effector T cells. J Immunol (2005) 175(2):713–9. doi:10.4049/jimmunol.175.2.713
22. Thivierge M, Turcotte S, Rola-Pleszczynski M, Stankova J. Enhanced cysteinyl-leukotriene type 1 receptor expression in T cells from house dust mite-allergic individuals following stimulation with Der p. J Immunol Res (2015) 2015:384780. doi:10.1155/2015/384780
Keywords: leukotriene B4, cysteinyl leukotriene, basophils, allergy and immunology, T cells
Citation: Chirumbolo S (2016) Commentary: Mutual interaction of basophils and T cells in chronic inflammatory diseases. Front. Immunol. 7:135. doi: 10.3389/fimmu.2016.00135
Received: 21 January 2016; Accepted: 27 March 2016;
Published: 08 April 2016
Edited by:
Liisa Kaarina Selin, University of Massachusetts Medical School, USAReviewed by:
Bibhuti Mishra, University of Massachusetts Medical School, USACopyright: © 2016 Chirumbolo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Salvatore Chirumbolo, salvatore.chirumbolo@univr.it